首页|基于临床药师和医联体平台对慢性心力衰竭患者用药临床观察与药学监护的研究

基于临床药师和医联体平台对慢性心力衰竭患者用药临床观察与药学监护的研究

扫码查看
目的 观察基于临床药师和医联体平台对慢性心力衰竭患者用药与药学监护的效果.方法 选取2020年9月-2022年10月我院就诊的420例慢性心力衰竭患者为研究对象,采用随机数字表法分为对照组(n=210)和观察组(n=210).对照组接受常规观察与治疗,观察组在对照组基础上给予基于医联体平台的临床药师监管,比较两组心功能指标[左心室舒张末期内径(LVEDD)、左室射血分数(LVEF)、每搏量(SV)、心脏指数(CI)]、自护能力、治疗费用、住院时间、再住院率、病死率、不良反应发生率.结果 观察组监管后LVEF、SV、CI高于对照组,LVEDD低于对照组(P<0.05);观察组监管后自理能力、用药依从性、对疾病相关知识认知评分均高于对照组(P<0.05);观察组治疗费用、住院时间均小于对照组(P<0.05);随访3个月,观察组再住院率、病死率均低于对照组(P<0.05);观察组不良反应发生率为4.76%,低于对照组的13.33%(P<0.05).结论 基于临床药师和医联体平台对慢性心力衰竭患者用药临床观察与药学监护的效果确切,可改善患者心功能指标,降低不良反应发生率,提高自护能力,预防再住院,降低病死率,改善患者预后.
Study on Clinical Observation and Pharmaceutical Care of Patients with Chronic Heart Failure Based on the Platform of Clinical Pharmacists and Medical Alliance
Objective To observe the clinical and pharmaceutical care effect of patients with chronic heart failure based on the platform of clinical pharmacists and medical alliance.Methods A total of 420 patients with chronic heart failure who were treated in our hospital from September 2020 to October 2022 were selected as the research objects.They were divided into control group(n=210)and observation group(n=210)by random number table method.The control group received routine observation and treatment,and the observation group was given clinical pharmacist supervision based on the medical alliance platform on the basis of the control group.The cardiac function indexes[left ventricular end-diastolic diameter(LVEDD),left ventricular ejection fraction(LVEF),stroke volume(SV),cardiac index(CI)],self-care ability,treatment cost,hospitalization time,rehospitalization rate,mortality rate and incidence of adverse reactions were compared between the two groups.Results After supervision,LVEF,SV and CI in the observation group were higher than those in the control group,and LVEDD was lower than that in the control group(P<0.05).The scores of self-care ability,medication compliance and cognition of disease-related knowledge in the observation group were higher than those in the control group(P<0.05).The treatment cost and hospitalization time of the observation group were lower than those of the control group(P<0.05).After 3 months of follow-up,the rehospitalization rate and mortality rate of the observation group were lower than those of the control group(P<0.05).The incidence of adverse reactions in the observation group was 4.76%,which was lower than 13.33%in the control group(P<0.05).Conclusion The clinical observation and pharmaceutical care of patients with chronic heart failure based on the platform of clinical pharmacists and medical alliance are effective.It can improve the cardiac function index of patients,reduce the incidence of adverse reactions,improve self-care ability,prevent rehospitalization,reduce mortality and improve the prognosis of patients.

Clinical pharmacistMedical alliance platformChronic heart failurePharmaceutical care

程贵胜、彭彩霞、许莺、曾凡长

展开 >

修水县第一人民医院心血管内科 江西修水 332400

修水县第一人民医院药剂科 江西修水 332400

修水县第一人民医院院感办 江西修水 332400

临床药师 医联体平台 慢性心力衰竭 药学监护

江西省卫生健康委科技项目

202311627

2024

医学信息
国家卫生部信息化管理领导小组 中国电子学会中国医药信息学分会 陕西文博生物信息工程研究所

医学信息

影响因子:0.161
ISSN:1006-1959
年,卷(期):2024.37(7)
  • 20